MedTrace Logo

Obliterating Diabetic Microangiopathy of the Diabetic Foot

NCT02610036 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2015-11-20

No results posted yet for this study

Summary

The purpose of this study will be the assessment of microangiopathy determined by the increase of capillary basement membrane thickness and decrease of capillary lumen area in the foot ulcer of 30 neuropathic and 30 neuroischemic type 2 diabetic patients

Conditions

  • Diabetic Foot

Sponsors & Collaborators

  • IRCCS Multimedica

    lead OTHER

Principal Investigators

  • Ezio Faglia, MD · IRCCS Multimedica

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-11-30
Completion
2013-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02610036 on ClinicalTrials.gov